Birinapant | 比瑞那帕 | MedChemExpress (MCE)
品牌 | 厂商性质 | 产地 | 货期 | 价格 |
---|---|---|---|---|
MedChemExpress (MCE) | 生产商 | 美国 | 现货 | 1953 |
性能特点
Birinapant (TL32711) 是一种二价 Smac 模拟物,是 XIAP 和 cIAP1 的强效拮抗剂,Kd 值分别为 45 nM 和小于 1 nM。Birinapant (TL3
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
10 mM * 1 mL | 1260251-31-7 | ¥1,953.00 | 询底价 |
Birinapant 产品活性:Birinapant (TL32711) 是一种二价 Smac 模拟物,是 XIAP 和 cIAP1 的强效拮抗剂,Kd 值分别为 45 nM 和小于 1 nM。Birinapant (TL32711) 诱导完整细胞中 cIAP1 和 cIAP2 的自身泛素化和蛋白酶体降解,从而形成 RIPK1: caspase-8 复合物,caspase-8 活化和诱导肿瘤细胞死亡。Birinapant (TL32711) 靶向与 TRAF2 相关的 cIAP,并消除 TNF 诱导的 NF-κB 活化。 产品来源: https://www.medchemexpress.cn/Birinapant.html 研究领域:Apoptosis | Anti-infection 作用靶点:IAP | Apoptosis | HIV In Vitro: Birinapant (TL32711) (30-10000 nM; 24 hours) significantly decreases the viability of SUM190 cells in a dose-dependent manner.? Birinapant (TL32711) (30-1000 nM; 4 hours) shows a significant decrease in cIAP1 levels and enhanced PARP cleavage, and induces apoptosis.? Birinapant (TL32711) binds with high affinity to the isolated BIR3 domains of cIAP1, cIAP2, and XIAP and the single BIR domain of ML-IAP and rapidly degrades TRAF2-bound cIAP1 and cIAP2 thereby inhibiting TNF-mediated NF-κB activation. In Vivo: Birinapant (TL32711) (30 mg/kg; i.p.; every third day (*5)) shows antitumor efficacy and are devoid of overt toxicity in preclinical models. 相关产品:Drug Repurposing Compound Library Plus | Clinical Compound Library Plus | Bioactive Compound Library Plus | Anti-Infection Compound Library | Apoptosis Compound Library | NF-κB Signaling Compound Library | Anti-Cancer Compound Library | Clinical Compound Library | Antiviral Compound Library | Peptidomimetic Library | Drug Repurposing Compound Library | Anti-COVID-19 Compound Library | Protein-protein Interaction Inhibitor Library | Anti-Prostate Cancer Compound Library | Heterocyclic Compound Library | Cell Death Library | Anti-Ovarian Cancer Compound Library | Multi-Target Compound Library | Bioactive Compound Library Max | MG-132 | Chloroquine | Doxorubicin hydrochloride | Bafilomycin A1 | Tamoxifen | Y-27632 | LY294002 | Paclitaxel | Z-VAD-FMK | Acetylcysteine | Angiotensin II human | 2-Deoxy-D-glucose | Staurosporine | Actinomycin D | SB-431542 | 5-Fluorouracil | Bortezomib | Deferoxamine mesylate | Oxaliplatin | Trametinib | Sorafenib | Temozolomide | Gemcitabine | Decitabine | Mdivi-1 | Rotenone | Etoposide | Elesclomol | Ruxolitinib | Monomethyl auristatin E 品牌介绍: MCE (MedChemExpress) 拥有数百种全球独家化合物,我们致力于为全球科研客户提供最新最全的高品质小分子活性化合物;10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域;设有专业的实验中心和严格的质控、验证体系;提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;产品的生物活性多经各国客户实验验证;Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果;专业团队跟踪最新的制药及生命科学研究进展,为您提供全球最新的活性化合物;与世界各大制药公司及知名科研机构建立了长期的合作。
Birinapant | 比瑞那帕 | MedChemExpress (MCE)信息由MedChemExpress (MCE)为您提供,如您想了解更多关于Birinapant | 比瑞那帕 | MedChemExpress (MCE)报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途